# Beneficial Effect of Intravenous Magnesium Sulphate in Term Neonates With Hypoxic Ischemic Encephalopathy(HIE)

> **NCT04705142** · PHASE2 · COMPLETED · sponsor: **Services Institute of Medical Sciences, Pakistan** · enrollment: 200 (actual)

## Conditions studied

- HIE

## Interventions

- **DRUG:** MgSo4

## Key facts

- **NCT ID:** NCT04705142
- **Lead sponsor:** Services Institute of Medical Sciences, Pakistan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-01
- **Primary completion:** 2020-12-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2021-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04705142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04705142, "Beneficial Effect of Intravenous Magnesium Sulphate in Term Neonates With Hypoxic Ischemic Encephalopathy(HIE)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04705142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*